1. Home
  2. NHS vs NYXH Comparison

NHS vs NYXH Comparison

Compare NHS & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NHS
  • NYXH
  • Stock Information
  • Founded
  • NHS 2003
  • NYXH 2009
  • Country
  • NHS United States
  • NYXH Belgium
  • Employees
  • NHS N/A
  • NYXH N/A
  • Industry
  • NHS Trusts Except Educational Religious and Charitable
  • NYXH Medical/Dental Instruments
  • Sector
  • NHS Finance
  • NYXH Health Care
  • Exchange
  • NHS Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • NHS 232.6M
  • NYXH 273.3M
  • IPO Year
  • NHS N/A
  • NYXH 2021
  • Fundamental
  • Price
  • NHS $7.41
  • NYXH $7.40
  • Analyst Decision
  • NHS
  • NYXH Strong Buy
  • Analyst Count
  • NHS 0
  • NYXH 4
  • Target Price
  • NHS N/A
  • NYXH $14.50
  • AVG Volume (30 Days)
  • NHS 111.8K
  • NYXH 49.7K
  • Earning Date
  • NHS 01-01-0001
  • NYXH 08-18-2025
  • Dividend Yield
  • NHS 13.44%
  • NYXH N/A
  • EPS Growth
  • NHS N/A
  • NYXH N/A
  • EPS
  • NHS N/A
  • NYXH N/A
  • Revenue
  • NHS N/A
  • NYXH $4,716,818.00
  • Revenue This Year
  • NHS N/A
  • NYXH $209.22
  • Revenue Next Year
  • NHS N/A
  • NYXH $219.37
  • P/E Ratio
  • NHS N/A
  • NYXH N/A
  • Revenue Growth
  • NHS N/A
  • NYXH N/A
  • 52 Week Low
  • NHS $6.95
  • NYXH $5.55
  • 52 Week High
  • NHS $9.17
  • NYXH $11.87
  • Technical
  • Relative Strength Index (RSI)
  • NHS 42.40
  • NYXH 46.80
  • Support Level
  • NHS $7.35
  • NYXH $6.90
  • Resistance Level
  • NHS $7.43
  • NYXH $7.60
  • Average True Range (ATR)
  • NHS 0.05
  • NYXH 0.34
  • MACD
  • NHS 0.00
  • NYXH -0.05
  • Stochastic Oscillator
  • NHS 47.00
  • NYXH 38.10

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: